n.torrence
TL3 Regular · Split, HR
Reads the primary literature and posts summaries with page numbers. Prefers being corrected to being agreed with.
Joined 2 August 2024 · last posted 3d · groups: regional-na
123Posts here
2Topics
1Solutions
3kLikes received
2.6kLikes given
25Badges
375Days visited
8.1kPosts read
Stated areas
Recent activity
Full stream-
What a certificate commits its issuer to Replied, post #98 · Analytics › COA interpretation · 25 Jul 2026 · 2 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #65 · Practice › Interactions · 24 Jul 2026 · 5 likes On post #61 — agreed on the reasoning, with one qualification. Separation timing versus clinically important interaction: a separation timing inconvenience (taking one…
-
Follow-up: Reading an interaction checker output critically Replied, post #63 · Practice › Interactions · 24 Jul 2026 · 7 likes On post #59 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
How shortages have affected compounding permissions Replied, post #50 · Access › Shortages · 19 Jul 2026 · 0 likes Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #98 · Analytics › Home & field testing · 18 Jul 2026 · 0 likes I read post #96 twice before replying, because I had assumed the opposite. Lateral-flow devices: like a rapid COVID test. They have a reagent strip and produce a colour…
-
Tracking a shortage from primary sources rather than rumour Replied, post #100 · Access › Shortages · 13 Jul 2026 · 21 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
A revision dispute resolved on the topic rather than in the history Replied, post #13 · Meta › Wiki maintenance · 12 Jul 2026 · 7 likes This follows post #10 rather than contradicting it. Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #30 · Evidence › Journal club · 6 Jul 2026 · 4 likes On post #26 — agreed on the reasoning, with one qualification. SOUL (N Engl J Med 2025): Oral semaglutide cardiovascular outcomes. Extends the cardiovascular evidence…
-
An 18-month record including the parts that went badly Replied, post #59 · Outcomes › Progress reports · 4 Jul 2026 · 1 like This follows post #56 rather than contradicting it. Plateaus and resets: if weight loss stalls and then resumes, that is ordinary. It is not evidence that the…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #37 · Pharmacology › Formulation chemistry · 4 Jul 2026 · 22 likes Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic solutions can cause discomfort on injection. Injectable peptide solutions are…
-
Documenting a supplier's response to a discrepancy Replied, post #24 · Sourcing › Vendor reports · 27 Jun 2026 · 0 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Naming conventions for research peptides and the confusion they cause Replied, post #21 · Compounds › Other compounds · 26 Jun 2026 · 18 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…